A recent study conducted by researchers at the Banaras Hindu University (BHU) says that nearly 30 per cent of the 926 recipients of Bharat Biotech's Covaxin reported experiencing adverse events of special interest (AESI).

Over 30% of Covaxin takers experienced nervous system disorders, menstrual abnormalities, suggests study

AstraZeneca withdrew its COVID-19 vaccine globally. The decision comes days after the company admitted that the vaccine can cause dangerous side effect. The application to withdraw the vaccine was made on March 5.

What reasons did AstraZeneca give while withdrawing its COVID-19 vaccine globally?

The significant rise in silent heart attack cases worldwide has been the point of discussion since the COVID-19 pandemic. The topic has again come under light after pharmaceutical giant AstraZeneca admitted that its COVID-19 vaccine Covishield may have adverse affect on some vaccine takers, with symptoms like blood clots and dip in platelet levels.

Shreyas Talpade on whether his heart attack was a result of Covid vaccine: ‘Never know what goes wrong..’

In India, the head of the Serum Institute which has tasked to develop the AstraZeneca based Covishield vaccine in the country now says, that the positive late state trial results of the candidates will allow it to seek emergency use approval by the year end.

Serum Institute, Bharat Biotech vaccines applied for emergency use in India

covidshield

Covidshield, News on Covidshield, stories on Covidshield, articles on Covidshield, Covidshield stories at Wion, Covidshield news, Covidshield latest news